Walter Rakowich - Ventas Independent Director
| VTR Stock | USD 66.53 1.59 2.45% |
Director
Mr. Walter C. Rakowich is Independent Director of the Company. He served as CEO of Prologis from November 2008 through June 2011, when Prologis and AMB Property Corporation merged. Following the merger, he served as coCEO of Prologis until December 31, 2012, when he retired. Before becoming CEO, Mr. Rakowich held a number of senior management positions at Prologis, including managing director and chief financial officer and president and chief operating officer. He served on the Prologis Board from January 2005 through December 2012. Prior to joining Prologis, Mr. Rakowich was a partner and principal with real estate provider Trammell Crow Company. He began his career at Price Waterhouse. He received his MBA from Harvard Business School and a BS, with distinction, from Pennsylvania State University since 2016.
| Age | 63 |
| Tenure | 9 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Walter Rakowich Latest Insider Activity
Tracking and analyzing the buying and selling activities of Walter Rakowich against Ventas stock is an integral part of due diligence when investing in Ventas. Walter Rakowich insider activity provides valuable insight into whether Ventas is net buyers or sellers over its current business cycle. Note, Ventas insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ventas'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Walter Rakowich over six months ago Disposition of 954 shares by Walter Rakowich of Iron Mountain at 81.33 subject to Rule 16b-3 |
Ventas Management Efficiency
The company has Return on Asset of 0.018 % which means that on every $100 spent on assets, it made $0.018 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/18/2025, Return On Tangible Assets is likely to drop to 0. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| James Morey | Universal Health Realty | 52 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Dana Hambly | National Health Investors | N/A | |
| Burke Whitman | Omega Healthcare Investors | 64 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
| James Jobe | National Health Investors | 59 | |
| Barbara Hill | Omega Healthcare Investors | 67 | |
| Henry Cole | Global Medical REIT | 76 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Robert McCabe | National Health Investors | 70 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Robert Webb | National Health Investors | 76 | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Robert Adams | National Health Investors | 74 | |
| Ronald Marston | Global Medical REIT | 78 | |
Management Performance
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0084 | ||||
| Return On Asset | 0.018 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 41.93 B | ||||
| Shares Outstanding | 437.14 M | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 99.51 % | ||||
| Number Of Shares Shorted | 12.13 M | ||||
| Price To Earning | 909.80 X |
Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.